Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
1. A compound of general formula:
wherein X and X′ are independently O or S;
Y is:
(a) substituted or unsubstituted phenyl wherein the substitutents are independently 1–5H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, (C 2 –C 4 )alkenyl, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, hydroxy, amino, cyano, or nitro; or
(b) substituted or unsubstituted 2-pyridyl, 3-pyridyl, or 4-pyridyl, wherein the substitutents are independently 1–4H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, (C 2 –C 4 )alkenyl, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, hydroxy, amino, cyano, or nitro;
R 1 and R 2 are independently: H; cyano; cyano-substituted or unsubstituted (C 1 –C 7 ) branched or straight-chain alkyl; cyano-substituted or unsubstituted (C 2 –C 7 ) branched or straight-chain alkenyl; cyano-substituted or unsubstituted (C 3 –C 7 ) branched or straight-chain alkenylalkyl; or together the valences of R 1 and R 2 form a (C 1 –C 7 ) cyano-substituted or unsubstituted alkylidene group (R a R b C═) wherein the sum of non-substituent carbons in R a and R b is 0–6;
R 3 is H, methyl, ethyl, n-propyl, isopropyl, or cyano;
R 4 , R 7 , and R 8 are independently: H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, (C 2 –C 4 )alkenyl, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, hydroxy, amino, cyano, or nitro; and
R 5 and R 6 are independently: H, (C 1 –C 4 )alkyl, (C 2 –C 4 )alkenyl, (C 3 –C 4 ) alkenylalkyl, halo (F, Cl, Br, I), C 1 –C 4 haloalkyl, (C 1 –C 4 )alkoxy, hydroxy, amino, cyano, nitro, or together as a linkage of the type (—OCHR 9 CHR 10 O—) form a ring with the phenyl carbons to which they are attached; wherein R 9 and R 10 are independently: H, halo, (C 1 –C 3 )alkyl, (C 2 –C 3 )alkenyl, (C 1 –C 3 )alkoxy(C 1 –C 3 )alkyl, benzoyloxy(C 1 –C 3 )alkyl, hydroxy(C 1 –C 3 )alkyl, halo(C 1 –C 3 )alkyl, formyl, formyl(C 1 –C 3 )alkyl, cyano, cyano(C 1 –C 3 )alkyl, carboxy, carboxy(C 1 –C 3 )alkyl, (C 1 –C 3 )alkoxycarbonyl(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylcarbonyl(C 1 –C 3 )alkyl, (C 1 –C 3 )alkanoyloxy(C 1 –C 3 )alkyl, amino(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylamino(C 1 –C 3 )alkyl (—(CH 2 ) n R c R e ), oximo (—CH═NOH), oximo(C 1 –C 3 )alkyl, (C 1 –C 3 )alkoximo (—C═NOR d ), alkoximo(C 1 –C 3 )alkyl, (C 1 –C 3 )carboxamido (—C(O)NR e R f ), (C 1 –C 3 )carboxamido(C 1 –C 3 )alkyl, (C 1 –C 3 )semicarbazido (—C═NNHC(O)NR e R f ), semicarbazido(C 1 –C 3 )alkyl, aminocarbonyloxy (—OC(O)NHR g ), aminocarbonyloxy(C 1 –C 3 )alkyl, pentafluorophenyloxycarbonyl, pentafluorophenyloxycarbonyl(C 1 –C 3 )alkyl, p-toluenesulfonyloxy(C 1 –C 3 )alkyl, arylsulfonyloxy(C 1 –C 3 )alkyl, (C 1 –C 3 )thio(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylsulfoxido(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylsulfonyl(C 1 –C 3 )alkyl, or (C 1 –C 5 )trisubstituted-siloxy(C 1 –C 3 )alkyl (—(CH 2 ) n SiOR d R e R g ); wherein n=1–3, R c and R d represent straight or branched hydrocarbon chains of the indicated length, R e , R f represent H or straight or branched hydrocarbon chains of the indicated length, R g represents (C 1 –C 3 )alkyl or aryl optionally substituted with halo or (C 1 –C 3 )alkyl, and R c , R d , R e , R f , and R g are independent of one another;
provided that
i when R 9 and R 10 are both H, or
ii when either R 9 or R 10 are halo, (C 1 –C 3 )alkyl, (C 1 –C 3 )alkoxy(C 1 –C 3 )alkyl, or benzoyloxy(C 1 –C 3 )alkyl, or
iii when R 5 and R 6 do not together form a linkage of the type (—OCHR 9 CHR 10 O—),
then the number of carbon atoms, excluding those of cyano substitution, for either or both of groups R 1 or R 2 is greater than 4, and the number of carbon atoms, excluding those of cyano substitution, for the sum of groups R 1 , R 2 , and R 3 is 10, 11, or 12.
2. The compound of claim 1 , wherein:
X and X′ are O;
Y is:
(a) substituted or unsubstituted phenyl wherein the substitutents are independently 1–5H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, cyano, or nitro; or
(b) substituted or unsubstituted 2-pyridyl, 3-pyridyl, or 4-pyridyl, wherein the substitutents are independently 1–4H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, cyano, or nitro;
R 1 and R 2 are independently: H; cyano; cyano-substituted or unsubstituted (C 1 –C 7 ) branched or straight-chain alkyl; cyano-substituted or unsubstituted (C 2 –C 7 ) branched or straight-chain alkenyl; cyano-substituted or unsubstituted (C 3 –C 7 ) branched or straight-chain alkenylalkyl; or together the valences of R 1 and R 2 form a (C 1 –C 7 ) cyano-substituted or unsubstituted alkylidene group (R a R b C═) wherein the sum of non-substituent carbons in R a and R b is 0–6;
R 3 is H, methyl, ethyl, or cyano;
R 4 , R 7 , and R 8 are independently: H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, cyano, or nitro; and
R 5 and R 6 are independently: H, (C 1 –C 4 )alkyl, halo (F, Cl, Br, I), C 1 –C 4 haloalkyl, (C 1 –C 4 )alkoxy, hydroxy, amino, cyano, nitro, or together as a linkage of the type (—OCHR 9 CHR 10 O—) form a ring with the phenyl carbons to which they are attached; wherein R 9 or R 10 is H, and the alternate R 9 or R 10 is: H, halo(C 1 –C 3 )alkyl, formyl, formyl(C 1 –C 3 )alkyl, cyano, cyano(C 1 –C 3 )alkyl, carboxy, carboxy(C 1 –C 3 )alkyl, amino(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylamino(C 1 –C 3 )alkyl (—(CH 2 ) n R c R e ), oximo (—CH═NOH), oximo(C 1 –C 3 )alkyl, (C 1 –C 3 )alkoximo (—C═NOR d ), alkoximo(C 1 –C 3 )alkyl, (C 1 –C 3 )carboxamido (—C(O)NR e R f ), (C 1 –C 3 )carboxamido(C 1 –C 3 )alkyl, (C 1 –C 3 )semicarbazido (—C═NNHC(O)NR e R f ), semicarbazido(C 1 –C 3 )alkyl, aminocarbonyloxy (—OC(O)NHR g ), aminocarbonyloxy(C 1 –C 3 )alkyl, pentafluorophenyloxycarbonyl, pentafluorophenyloxycarbonyl(C 1 –C 3 )alkyl, p-toluenesulfonyloxy(C 1 –C 3 )alkyl, arylsulfonyloxy(C 1 –C 3 )alkyl, (C 1 –C 3 )thio(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylsulfoxido(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylsulfonyl(C 1 –C 3 )alkyl, or (C 1 –C 5 )trisubstituted-siloxy(C 1 –C 3 )alkyl (—(CH 2 ) n SiOR d R e R g ); wherein n=1–3, R c and R d represent straight or branched hydrocarbon chains of the indicated length, R e , R f represent H or straight or branched hydrocarbon chains of the indicated length, R g represents (C 1 –C 3 )alkyl or aryl optionally substituted with halo or (C 1 –C 3 )alkyl, and R c , R d , R e , R f , and R g are independent of one another;
provided that
i when R 9 and R 10 are both H, or
ii when R 5 and R 6 do not together form a linkage of the type (—OCHR 9 CHR 10 O—),
then the number of carbon atoms, excluding those of cyano substitution, for either or both of groups R 1 or R 2 is greater than 4, and the number of carbon atoms, excluding those of cyano substitution, for the sum of groups R 1 , R 2 , and R 3 is 10, 11, or 12.
3. The compound of claim 2 wherein:
X and X′ are O;
Y is:
(a) substituted or unsubstituted phenyl wherein the substitutents are independently 1–5H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, cyano, or nitro; or
(b) substituted or unsubstituted 2-pyridyl, 3-pyridyl, or 4-pyridyl, wherein the substitutents are independently 1–4H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, cyano, or nitro;
R 1 and R 2 are independently: H; cyano; cyano-substituted or unsubstituted (C 1 –C 7 ) branched or straight-chain alkyl; cyano-substituted or unsubstituted (C 2 –C 7 ) branched or straight-chain alkenyl; cyano-substituted or unsubstituted (C 3 –C 7 ) branched or straight-chain alkenylalkyl; or together the valences of R 1 and R 2 form a (C 1 –C 7 ) cyano-substituted or unsubstituted alkylidene group (R a R b C═) wherein the sum of non-substituent carbons in R a and R b is 0–6;
R 3 is H, methyl, ethyl, or cyano;
R 4 , R 7 , and R 8 are independently: H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl, cyano, or nitro; and
R 5 and R 6 are independently: H, (C 1 –C 4 )alkyl, halo (F, Cl, Br, I), C 1 –C 4 haloalkyl, (C 1 –C 4 )alkoxy, hydroxy, amino, cyano, nitro, or together as a linkage of the type (—OCHR 9 CHR 10 O—) form a ring with the phenyl carbons to which they are attached; wherein R 9 or R 10 is H, and the alternate R 9 or R 10 is: H, halo(C 1 –C 3 )alkyl, formyl, formyl(C 1 –C 3 )alkyl, cyano, cyano(C 1 –C 3 )alkyl, carboxy, carboxy(C 1 –C 3 )alkyl, amino(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylamino(C 1 –C 3 )alkyl (—(CH 2 ) n R c R e ), oximo (—CH═NOH), oximo(C 1 –C 3 )alkyl, (C 1 –C 3 )alkoximo (—C═NOR d ), alkoximo(C 1 –C 3 )alkyl, (C 1 –C 3 )carboxamido (—C(O)NR e R f ), (C 1 –C 3 )carboxamido(C 1 –C 3 )alkyl, (C 1 –C 3 )semicarbazido (—C═NNHC(O)NR e R f ), semicarbazido(C 1 –C 3 )alkyl, aminocarbonyloxy (—OC(O)NHR g ), aminocarbonyloxy(C 1 –C 3 )alkyl, pentafluorophenyloxycarbonyl, pentafluorophenyloxycarbonyl(C 1 –C 3 )alkyl, p-toluenesulfonyloxy(C 1 –C 3 )alkyl, arylsulfonyloxy(C 1 –C 3 )alkyl, (C 1 –C 3 )thio(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylsulfoxido(C 1 –C 3 )alkyl, (C 1 –C 3 )alkylsulfonyl(C 1 –C 3 )alkyl, or (C 1 –C 5 )trisubstituted-siloxy(C 1 –C 3 )alkyl (—(CH 2 ) n SiOR d R e R g ); wherein n=1–3, R c and R d represent straight or branched hydrocarbon chains of the indicated length, R e , R f represent H or straight or branched hydrocarbon chains of the indicated length, R g represents (C 1 –C 3 )alkyl or aryl optionally substituted with halo or (C 1 –C 3 )alkyl, and R c , R d , R e , R f , and R g are independent of one another;
provided that
i when R 9 and R 10 are both H, or
ii when R 5 and R 6 do not together form a linkage of the type (—OCHR 9 CHR 10 O—),
then the number of carbon atoms, excluding those of cyano substitution, for either or both of groups R 1 or R 2 is greater than 4, and the number of carbon atoms, excluding those of cyano substitution, for the sum of groups R 1 , R 2 , and R 3 is 10, 11, or 12; and
when R 5 and R 6 together as a linkage of the type (—OCHR 9 CHR 10 O—) form a ring with the phenyl carbons to which they are attached, and R 9 and R 10 are not both H,
then R 1 and R 2 are (C 1 –C 4 ) straight or branched alkyl, and R 3 is H or methyl.
4. The compound of claim 3 wherein:
X and X′ are O;
Y is:
(a) substituted or unsubstituted phenyl wherein the substitutents are independently 1–5H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl; or
(b) substituted or unsubstituted 3-pyridyl, wherein the substitutents are independently 1–4H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl;
R 1 and R 2 are independently: H; cyano; cyano-substituted or unsubstituted (C 1 –C 7 ) branched or straight-chain alkyl; cyano-substituted or unsubstituted (C 2 –C 7 ) branched or straight-chain alkenyl; cyano-substituted or unsubstituted (C 3 –C 7 ) branched or straight-chain alkenylalkyl; or together the valences of R 1 and R 2 form a (C 1 –C 7 ) cyano-substituted or unsubstituted alkylidene group (R a R b C═) wherein the sum of non-substituent carbons in R a and R b is 0–3;
R 3 is methyl;
R 4 , R 7 , and R 8 are independently selected from: H, (C 1 –C 4 )alkyl, (C 1 –C 4 )alkoxy, halo (F, Cl, Br, I), (C 1 –C 4 )haloalkyl; and
R 5 and R 6 are independently: H, (C 1 –C 4 )alkyl, halo (F, Cl, Br, I), C 1 –C 4 haloalkyl, (C 1 –C 4 )alkoxy, or together as a linkage of the type (—OCHR 9 CHR 10 O—) form a ring with the phenyl carbons to which they are attached; wherein R 9 or R 10 is H, and the alternate R 9 or R 10 is: H, halo(C 1 –C 2 )alkyl, formyl, cyano(C 1 –C 2 )alkyl, carboxy, amino(C 1 –C 2 )alkyl, oximo (—CH═NOH), (C 1 –C 3 )carboxamido (—C(O)NR e R f ), (C 1 –C 2 )semicarbazido (—C═NNHC(O)NR e R f ), aminocarbonyloxy (—OC(O)NHR g ), pentafluorophenyloxycarbonyl, p-toluenesulfonyloxy(C 1 –C 3 )alkyl, methylthio(C 1 –C 2 )alkyl, methylsulfoxido(C 1 –C 2 )alkyl, methylsulfonyl(C 1 –C 2 )alkyl, or (C 1 –C 5 )trisubstituted-siloxy(C 1 –C 3 )alkyl (—(CH 2 ) n SiOR d R e R g ); wherein n=1–3, R d represents a straight or branched hydrocarbon chain of the indicated length, R e , R f represent H or straight or branched hydrocarbon chains of the indicated length, R g represents (C 1 –C 3 )alkyl or aryl optionally substituted with halo or (C 1 –C 3 )alkyl, and R c , R d , R e , R f , and R g are independent of one another;
provided that
i) when R 9 and R 10 are both H, or
ii) when R 5 and R 6 do not together form a linkage of the type (—OCHR 9 CHR 10 O—),
then the number of carbon atoms, excluding those of cyano substitution, for either or both of groups R 1 or R 2 is greater than 4, and the number of carbon atoms, excluding those of cyano substitution, for the sum of groups R 1 , R 2 , and R 3 is 10, 11, or 12; and
when R 5 and R 6 together as a linkage of the type (—OCHR 9 CHR 10 O—) form a ring with the phenyl carbons to which they are attached, and R 9 and R 10 are not both H,
then R 1 and R 2 are methyl.
5. The compound of claim 4 selected from the group consisting of:
a) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(3-hydroxymethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
b) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-[3-(tert-butyl-dimethyl-silanyloxymethyl)-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl]-hydrazide,
c) 7-[N′-tert-Butyl-N′-(3,5-dimethyl-benzoyl)-hydrazinocarbonyl]-8-methyl-2,3-dihydro-benzo[1,4]dioxine-2-carboxylic acid,
d) 7-[N′-tert-Butyl-N′-(3,5-dimethyl-benzoyl)-hydrazinocarbonyl]-8-methyl-2,3-dihydro-benzo[1,4]dioxine-2-carboxylic acid methyl ester,
e) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(3-semicarbazidomethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
f) Phenyl-carbamic acid 7-[N′-tert-butyl-N′-(3,5-dimethyl-benzoyl)-hydrazinocarbonyl]-8-methyl-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester,
g) 3,5-Dimethyl-benzoic acid N′-[3-(2-amino-ethyl)-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl]-N-tert-butyl-hydrazide,
h) 7[N′-tert-Butyl-N′-(3,5-dimethyl-benzoyl)-hydrazinocarbonyl]-8-methyl-2,3-dihydro-benzo[1,4]dioxine-2-carboxylic acid pentafluorophenyl ester,
i) 7-[N′-tert-Butyl-N′-(3,5-dimethyl-benzoyl)-hydrazinocarbonyl]-8-methyl-2,3-dihydro-benzo[1,4]dioxine-2-carboxylic acid methylamide,
j) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(3-formyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
k) Toluene-4-sulfonic acid 7-[N′-tert-butyl-N′-(3,5-dimethyl-benzoyl)-hydrazinocarbonyl]-8-methyl-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester,
l) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-[3-(hydroxyimino-methyl)-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl]-hydrazide,
m) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(3-cyanomethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
n) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(5-methyl-3-methylsulfanylmethyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
o) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(3-methanesulfonylmethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
p) 3,5-Dimethyl-benzoic acid N-tert-butyl-N′-(3-fluoromethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide,
q) 3,5-Dimethyl-benzoic acid N-(1-tert-butyl-heptyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide,
r) 3,5-Dimethyl-benzoic acid N-(1-tert-butyl-heptyl)-N′-(4-ethyl-benzoyl)-hydrazide,
s) 3,5-Dimethoxy-4-methyl-benzoic acid-N-(1-tert-butyl-heptyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide,
t) 3,5-Dimethoxy-4-methyl-benzoic acid-N-(1-tert-butyl-heptyl)-N′-(4-ethyl-benzoyl)-hydrazide,
u) 2-Methoxy-nicotinic acid N-(1-tert-butyl-heptyl)-N′-(4-ethyl-benzoyl)-hydrazide,
v) 3,5-Dimethyl-benzoic acid N-(1-tert-butyl-3,4,4-trimethyl-pent-2-enyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide,
w) 3,5-Dimethyl-benzoic acid N-(1-tert-butyl-2-cyano-vinyl)-N′-(3-methoxy-2-methylbenzoyl)-hydrazide,
x) 3,5-Dimethyl-benzoic acid N-(1-butyl-2,2-dimethyl-pentyl)-N′-(3-methoxy-2-methylbenzoyl)-hydrazide, and
y) 3,5-Dimethyl-benzoic acid N-(1-butyl-2,2-di methyl-pent-4-enyl)-N′-(3-methoxy-2-methyl-benzoyl)-hydrazide.